Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fludarabine: a review.

M A Hood1, R S Finley

  • 1University of Maryland Cancer Center, Baltimore 21201.

DICP : the Annals of Pharmacotherapy
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Fludarabine shows promise for chronic lymphocytic leukemia (CLL) treatment. Doses effective for CLL are within tolerated limits, unlike those for acute leukemias where toxicity is a concern.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Processing and Storing Oyster Meats on Concentrations of Indicator Bacteria, Vibrios and Aeromonas hydrophila.

Journal of food protection·2019
Same author

Effect of Processing and Storing Oyster Meats on Concentrations of Indicator Bacteria, Vibrios and Aeromonas hydrophila.

Journal of food protection·2019
Same author

Interaction between an ammonium-oxidizer,Nitrosomonas sp., and two heterotrophic bacteria,Nocardia atlantica andPseudomonas sp.: A note.

Microbial ecology·2013
Same author

Effects of temperature, ph, salinity, and inorganic nitrogen on the rate of ammonium oxidation by nitrifiers isolated from wetland environments.

Microbial ecology·2013
Same author

Distribution ofVibrio cholerae in two Florida estuaries.

Microbial ecology·2013
Same author

Distribution of ultramicrobacteria in a gulf coast estuary and induction of ultramicrobacteria.

Microbial ecology·2013
Same journal

Eradication of methicillin-resistant Staphylococcus aureus vaginitis with mupirocin.

DICP : the annals of pharmacotherapy·1991
Same journal

Ketorolac formulary restriction and usage evaluation.

DICP : the annals of pharmacotherapy·1991
Same journal

Oral vancomycin-induced rash: case report and review of the literature.

DICP : the annals of pharmacotherapy·1991
Same journal

Imipenem/cilastatin drug utilization evaluation in a large community hospital.

DICP : the annals of pharmacotherapy·1991
Same journal

Pharmacist involvement in Society of Critical Care Medicine.

DICP : the annals of pharmacotherapy·1991
Same journal

Early anticoagulation therapy in deep vein thrombosis.

DICP : the annals of pharmacotherapy·1991
See all related articles

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Fludarabine is a novel fluorinated adenine analog.
  • Existing nucleoside analogs include cytarabine (antileukemic) and vidarabine (antiviral).
  • Fludarabine exhibits resistance to adenosine deaminase deactivation, unlike vidarabine.

Purpose of the Study:

  • To evaluate the efficacy and toxicity of fludarabine in various tumor types.
  • To determine the therapeutic potential of fludarabine in different leukemias.
  • To compare fludarabine's tolerability in acute leukemias versus chronic lymphocytic leukemia (CLL).

Main Methods:

  • Phase I and II clinical trials were conducted.
  • Efficacy and toxicity data were collected across multiple tumor types.
  • Dose-response and tolerability were assessed for different leukemias.

Related Experiment Videos

Main Results:

  • Fludarabine demonstrated potential efficacy in acute lymphocytic leukemia, acute nonlymphocytic leukemia, and CLL.
  • Effective doses for acute leukemias exceeded the maximum tolerated dose, causing severe toxicity.
  • Doses for satisfactory response in CLL were within tolerated limits.
  • Observed toxicities include hematologic issues, neurotoxicity, and organ abnormalities.

Conclusions:

  • Fludarabine is a potentially effective agent for CLL at well-tolerated doses.
  • High-dose fludarabine is associated with significant toxicity in acute leukemias.
  • Further long-term survival data are needed, but response correlates with survival in similar agents.